Health Catalyst (NASDAQ:HCAT – Get Free Report) and Movano (NASDAQ:MOVE – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings.
Profitability
This table compares Health Catalyst and Movano’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Health Catalyst | -34.05% | -6.67% | -3.21% |
| Movano | -3,409.60% | -647.91% | -225.03% |
Analyst Ratings
This is a breakdown of current ratings and price targets for Health Catalyst and Movano, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Health Catalyst | 1 | 8 | 5 | 0 | 2.29 |
| Movano | 1 | 0 | 0 | 0 | 1.00 |
Risk & Volatility
Health Catalyst has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Movano has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.
Insider & Institutional Ownership
85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 16.6% of Movano shares are held by institutional investors. 2.6% of Health Catalyst shares are held by insiders. Comparatively, 10.4% of Movano shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Valuation & Earnings
This table compares Health Catalyst and Movano”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Health Catalyst | $306.58 million | 0.55 | -$69.50 million | ($1.59) | -1.50 |
| Movano | $1.01 million | 5.87 | -$23.73 million | ($10.83) | -0.66 |
Movano has lower revenue, but higher earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Movano, indicating that it is currently the more affordable of the two stocks.
Summary
Health Catalyst beats Movano on 10 of the 14 factors compared between the two stocks.
About Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
About Movano
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.
